Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

EDC Insights: Before, During, and After

Session Chair(s)

Maryanne  Nicosia, MS

Maryanne Nicosia, MS

Executive Director, Clinical Data Management

Neurocrine Biosciences, Inc, United States

Electronic Data Capture: The Importance and Impact of Selecting the Optimum EDC Platform for Your Clinical Program

Learning Objective : Discuss the importance of ensuring optimum efficiency gains from selecting an EDC system; Define a list of questions (quantitative framework) that can be used to assist in EDC system selection; Evaluate ROI from choosing the appropriate EDC system; Explain the quantitative and qualitative costs of switching EDC platforms; Identify the most common EDC challenges and cost-effective solutions; Discuss trends in conducting postmarketing trials using EDC, focusing on changing needs/priorities.

Speaker(s)

Kent  Mahoney, MBA

Love the One You're With: The High Costs of Switching EDC Platforms and How to Get the Most Out of Your Current One

Kent Mahoney, MBA

Soltex Consulting LLP, United States

Managing Director

Patrick  Chassaigne, MS

Considerations for Using EDC in Late Phase Research

Patrick Chassaigne, MS

Medidata Solutions Worldwide, United States

Director, CRO Partnerships, Americas

Toby  Odenheim, MBA

Electronic Data Capture: The Importance and Impact of Selecting the Optimum EDC Platform for Your Clinical Program

Toby Odenheim, MBA

Parker Institute For Cancer Immunotherapy, United States

Director, Technology & Governance

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.